Apton Biosystems snags $24m Series A

Apton Biosystems Inc, a developer of Super-Res sequencing and single-molecule detection systems for large-scale clinical applications, has raised $24 million in Series A financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this